OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
Group Type: Fund Manager Circles
About the Company
OmniScience Capital, founded by Dr. Vikas Gupta, is a global investment management firm renowned for its scientific and disciplined approach to equity investing. The firm is at the forefront of global investing for Indian investors, offering carefully curated, SuperNormal Portfolios that prioritize safety, sustainable growth, and long-term returns.
Leveraging the vision of India’s transformation during the Amrit Kaal (2022–2047), OmniScience Capital integrates domestic opportunities with global exposure—especially in developed markets like the U.S., where transformative technology companies drive exceptional performance.
Disclaimer: Investments in securities are subject to market risks. Please read all related documents carefully before investing. SEBI registration, BASL membership, and NISM certification do not guarantee performance or returns. Please read detailed disclaimer at: https://www.omnisciencecapital.com/disclaimer/
For more information, visit OmniScience Capital’s Scientific Investing page.-https://www.omnisciencecapital.com/
OmniScience Investment Adviser is the advisory division of OmniScience Capital Advisors Pvt. Ltd., registered as a non-individual Investment Adviser with SEBI (Registration No. INA000007623, BASL Membership Id 1197, CIN U93000MH2017PTC290053).
-
Public
-
72
Posts -
20
Members
-
-
-
-
VRIGHT Exchange – Daily Digest posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
9 months, 3 weeks agoInvestor Education | Economic Times Article | By Dr Vikas Gupta, CEO and Chief Investment Strategist, OmniScience Capital
Please click to read more
https://m.economictimes.com/markets/stocks/news/warren-buffetts-2025-mantra-adapt-to-reality-reality-wont-adapt-to-your-risk-tolerance/amp_articleshow/121530109.cms -
VRIGHT Exchange – Daily Digest posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoStocks in Action | Rail stocks riding the defence wave | OmniScience Capital View
Vikas Gupta of OmniScience Capital argues that the rise in rail stocks may well be an extension of the broader defence theme. With Operation Sindoor still potentially active, there is likely increased focus on logistics, mobilisation and connectivity — all of w…[Read more]
Reacted by Ayesha Aryan Rana And 1 Other -
-
VRIGHT Exchange – Daily Digest posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoBanks, IT to defence: Dr Vikas Gupta of OmniScience Capital lists sectors that can turn wealth creators over 3-5 years
https://www.livemint.com/market/stock-market-news/banks-it-to-defence-dr-vikas-gupta-of-omniscience-capital-lists-sectors-that-can-turn-wealth-creators-over-3-5-years-11747715027359.html -
VRIGHT Exchange – Daily Digest posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoऑपरेशन सिंदूर बना डिफेंस स्टॉक्स का ब्रह्मास्त्र, ₹1.8 लाख करोड़ की रैली; लेकिन क्या अब गिरावट की संभावना? Read More
https://hindi.economictimes.com/markets/share-bazaar/operation-sindoor-indian-defence-stocks-rally-ideaforge-cochin-shipyard-hal-grse-bel-hindustan-aeronautics-…[Read more] -
VRIGHT Exchange – Daily Digest joined the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months ago -
VRIGHT Exchange – CEO’s Desk posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoDefence stocks detonate in Rs 1.8 lakh crore boom. Is a ceasefire on the charts?
Ashwini Shami of OmniScience Capital has issued a caution, stating that valuations have become quite expensive. He points out, “The Nifty Defence Index has surged 60% from its February 2025 low, and its current P/E ratio stands at 61 — close to the overheated levels o…[Read more] -
VRIGHT Exchange – CEO’s Desk posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoCDMO market in pharma sector is a great opportunity for India to establish its supremacy in one more highly scientific and technical area of expertise. The market is growing at a fast pace of around 15+ percent CAGR. This is a very exciting growth vector, said Vikas Gupta of Omniscience Capital. Read More…[Read more]
-
VRIGHT EXCHANGE joined the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months ago -
Ayesha Aryan Rana posted an update in the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months agoऑम्नीसाइंस कैपिटल की सलाह है कि दीर्घकालिक निवेशकों को न घबराना चाहिए, न ही बाज़ार की प्रवृत्तियों का अंधानुकरण करते हुए अवसर छूटने के भय (FOMO) का शिकार होना चाहिए। इसके बजाय, उन्हें उन क्षेत्रों और कंपनियों की एक सूची तैयार करनी चाहिए जिनमें दीर्घकालिक संभावना हो और जब वे उचित मूल्यांकन पर उपलब्ध हों, तो धीरे-धीरे निवेश करना चाहिए।
Please r…[Read more]
Reacted by VRIGHT Exchange – CEO’s Desk -
-
Ayesha Aryan Rana joined the group OmniScience Capital-Enhance Safety • Enhance Growth • Enhance Returns
10 months ago

